KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Change in Receivables (2016 - 2025)

HCA Healthcare (HCA) has disclosed Change in Receivables for 12 consecutive years, with $439.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 48.59% to $439.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $94.0 million, a 88.24% decrease, with the full-year FY2025 number at $94.0 million, down 88.24% from a year prior.
  • Change in Receivables was $439.0 million for Q4 2025 at HCA Healthcare, up from -$25.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $854.0 million in Q4 2024 to a low of -$647.0 million in Q2 2025.
  • A 5-year average of $179.4 million and a median of $195.5 million in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: surged 890.0% in 2023, then crashed 431.79% in 2025.
  • HCA Healthcare's Change in Receivables stood at -$350.0 million in 2021, then soared by 188.57% to $310.0 million in 2022, then skyrocketed by 147.42% to $767.0 million in 2023, then increased by 11.34% to $854.0 million in 2024, then plummeted by 48.59% to $439.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Change in Receivables are $439.0 million (Q4 2025), -$25.0 million (Q3 2025), and -$647.0 million (Q2 2025).